$0.282
-0.041 (-14.47%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
EVGN-Prognose durch Analyse ähnlicher Charts
Alphio's EVGN stock price prediction model matches the current Evogene Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.28 (+0.02%). The 1-week path is $0.28 (-1.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Evogene Ltd-Aktien kaufen?
Evogene Ltd is not a good buy right now due to significant financial losses and poor performance metrics. The current price is $0.2819, with a 52-week high of $1.28, indicating a substantial decline of 76.21% over the past year. Additionally, the RSI is extremely low at 8.602, suggesting oversold conditions but also a lack of buying momentum. The company reported a net loss of $1.8 million in Q2 2026, which is a 62% improvement year-over-year, but still reflects ongoing financial struggles. The main risk is the proxy fight with shareholders, which could further destabilize the company's management and strategy.
EVGN schloss am Friday bei $0.28, nachdem der Kurs -14.47% fallen
Evogene Ltd (EVGN) last closed at $0.2819, losing -14.47%. These facts feed the 1-day and 1-week EVGN price prediction above.
Analystenkonsens
Evogene Ltd (EVGN): 1 Kaufen, 1 Halten, 0 Verkaufen. Ausblick: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Evogene Ltd (EVGN) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf EVGN am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für EVGN
Historically the probability of a positive November return for EVGN is 0.00%. January offers the highest probability of a positive month at 16.39%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-Jahres-Kursprojektionen für EVGN
| Monat | Tiefstkurs | Ø-Kurs | Höchstkurs | Potenzieller ROI |
|---|---|---|---|---|
| Nov 2026 | $1.09 | $1.49 | $1.93 | +428.61% |
| Dec 2026 | $0.96 | $1.31 | $1.65 | +364.79% |
Für 2026 wird für Evogene Ltd (EVGN) eine Spanne von $0.96 bis $1.93 projiziert.
Monatsprognose 2026 für Evogene Ltd
Im Nov 2026 wird für Evogene Ltd ein Durchschnitt von $1.49 erwartet, mit einem Tief von $1.09 und einem Hoch von $1.93.
Im Dec 2026 wird für Evogene Ltd ein Durchschnitt von $1.31 erwartet, mit einem Tief von $0.96 und einem Hoch von $1.65.
Ähnliche Artikel
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.